GNLX - Genelux Corporation Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
5.28 0.26 (4.92%)	---	---	---	---	0.17 (3.22%)	0.0 (0.0%)	0.0 (0.0%)

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.2
Diluted EPS:: -0.2
Basic P/E:: -27.7
Diluted P/E:: -27.7
RSI(14) 1m:: 100.0
VWAP:: 5.54
RVol:: 1.4888

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	5.46 -0.09 (-1.71%)	Oct 15 09:52
1m	Price increase 1m	5.59 +0.16 (+2.85%)	Oct 15 09:37
60m	Price increase 60m	5.59 +0.3 (+5.78%)	Oct 15 09:37
1m	Price increase 1m	5.49 +0.09 (+1.67%)	Oct 15 09:34
10m	Price increase 10m	5.49 +0.21 (+3.98%)	Oct 15 09:34